Brilinta and Eloctate with Fc Fusion Protein recombinant

• Generic Name: ticagrelor
• Dosage Forms: tablet
• Other Brand Names: Brilinta

Brilinta (ticagrelor) prevents platelets in your blood from sticking together to form an unwanted blood clot that could block an artery.

Brilinta is used together with aspirin to lower your risk of having a stroke, serious heart problems, or death after you've had a heart attack or severe chest pain (angina). It is also used to prevent blood clots in people that have had a stent placed in their heart.

Brilinta may also be used for purposes not listed in this medication guide.

• Generic Name: antihemophilic factor
• Dosage Forms: n.a.
• Other Brand Names: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur

Eloctate with Fc Fusion Protein is a naturally occurring protein in the blood that helps blood to clot. A lack of antihemophilic factor VIII is the cause of hemophilia A. Recombinant this medicine works by temporarily raising levels of factor VIII in the blood to aid in clotting.

Recombinant Eloctate with Fc Fusion Protein is used to treat or prevent bleeding episodes in adults and children with hemophilia A. It is also used to control bleeding related to surgery or dentistry in a person with hemophilia, and to prevent joint damage in people age 16 or older with severe hemophilia A and no prior joint damage.

Recombinant Eloctate with Fc Fusion Protein is not for use in people with von Willebrand disease.

Recombinant Eloctate with Fc Fusion Protein may also be used for purposes not listed in this medication guide.